• 1
    Metcalfe, D. D., Baram, D. and Mekori, Y. A., Mast cells. Physiol. Rev. 1997. 77: 10331079.
  • 2
    Bradding, P., Human mast cell cytokines. Clin. Exp. Allergy 1996. 26: 1319.
  • 3
    Feger, F., Varadaradjalou, S., Gao, Z., Abraham, S. N. and Arock, M., The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 2002. 23: 151158.
  • 4
    Malaviya, R., Ikeda, T., Ross, E. and Abraham, S. N., Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 1996. 381: 7780.
  • 5
    Leal-Berumen, I., Conlon, P. and Marshall, J. S., IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 1994. 152: 54685476.
  • 6
    Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S. and Ulevitch, R. J., Structure and function of lipopolysaccharide binding protein. Science 1990. 249: 14291431.
  • 7
    Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. and Mathison, J. C., CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990. 249: 14311433.
  • 8
    Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B. and Wright, S. D., Soluble CD14 participates in the response ofcells to lipopolysaccharide. J. Exp. Med. 1992. 176: 16651671.
  • 9
    Medzhitov, R. and Janeway, C., Jr., Innate immune recognition: mechanisms and pathways. Immunol. Rev. 2000. 173: 8997.
  • 10
    Beutler, B. and Poltorak, A., Sepsis and evolution of the innate immune response. Crit. Care. Med. 2001. 29: S2–S6; discussion S6–S7.
  • 11
    Verhoef, J. and Mattsson, E., The role of cytokines in gram-positive bacterial shock. Trends Microbiol. 1995. 3: 136140.
  • 12
    Aderem, A. and Ulevitch, R. J., Toll-like receptors in the induction of the innate immune response. Nature 2000. 406: 782787.
  • 13
    Akira, S., Takeda, K. and Kaisho, T., Toll-like receptors: critical proteins linking innate andacquired immunity. Nat. Immunol. 2001. 2: 675680.
  • 14
    Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S., Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999. 11: 443451.
  • 15
    Werts, C., Tapping, R. I., Mathison, J. C., Chuang, T. H., Kravchenko, V., Saint Girons, I., Haake, D. A., Godowski, P. J., Hayashi, F., Ozinsky, A., Underhill, D. M., Kirschning, C. J., Wagner, H., Aderem, A., Tobias, P. S. and Ulevitch, R. J., Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2001. 2: 346352.
  • 16
    Hirschfeld, M., Weis, J. J., Toshchakov, V., Salkowski, C. A., Cody, M. J., Ward, D. C., Qureshi, N., Michalek, S. M. and Vogel, S. N., Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 2001. 69: 14771482.
  • 17
    Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. and Akira, S., Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999. 162: 37493752.
  • 18
    McCurdy, J. D., Lin, T. J. and Marshall, J. S., Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 2001. 70: 977984.
  • 19
    Supajatura, V., Ushio, H., Nakao, A., Akira, S., Okumura, K., Ra, C. and Ogawa, H., Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 2002. 109: 13511359.
  • 20
    Bischoff, S. C., Sellge, G., Lorentz, A., Sebald, W., Raab, R. and Manns, M. P., IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. USA 1999. 96: 80808085.
  • 21
    Frantz, S., Kobzik, L., Kim, Y. D., Fukazawa, R., Medzhitov, R., Lee, R. T. and Kelly, R. A., Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 1999. 104: 271280.
  • 22
    Cario, E. and Podolsky, D. K., Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 2000. 68: 70107017.
  • 23
    Song, P. I., Abraham, T. A., Park, Y., Zivony, A. S., Harten, B., Edelhauser, H. F., Ward, S. L., Armstrong, C. A. and Ansel, J. C., The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Invest. Ophthalmol. Vis. Sci. 2001. 42: 28672877.
  • 24
    Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. and Aderem, A., The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 2000. 97: 1376613771.
  • 25
    Takeuchi, O., Kawai, T., Muhlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K. and Akira, S., Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001. 13: 933940.
  • 26
    Liu, C., Xu, Z., Gupta, D. and Dziarski, R., Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J. Biol. Chem. 2001. 276: 3468634694.
  • 27
    Mita, Y., Dobashi, K., Endou, K., Kawata, T., Shimizu, Y., Nakazawa, T. and Mori, M., Toll-like receptor 4 surface expression on human monocytes and B cells is modulated by IL-2 andIL-4. Immunol. Lett. 2002. 81: 7175.
  • 28
    Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K. and Kimoto, M., MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999. 189: 17771782.
  • 29
    Kaisho, T. and Akira, S., Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 2001. 22: 7883.
  • 30
    Perera, P. Y., Mayadas, T. N., Takeuchi, O., Akira, S., Zaks-Zilberman, M., Goyert, S. M. and Vogel, S. N., CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 2001. 166: 574581.
  • 31
    Gupta, D., Kirkland, T. N., Viriyakosol, S. and Dziarski, R., CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 1996. 271: 2331023316.
  • 32
    Schneider, E., Rolli-Derkinderen, M., Arock, M. and Dy, M., Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002. 23: 255263.
  • 33
    Caron, G., Delneste, Y., Roelandts, E., Duez, C., Bonnefoy, J. Y., Pestel, J. and Jeannin, P., Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 2001. 167: 36823686.
  • 34
    Masuda, A., Yoshikai, Y., Aiba, K. and Matsuguchi, T., Th2 cytokineproduction from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways. J. Immunol. 2002. 169: 38013810.
  • 35
    Royer, B., Varadaradjalou, S., Saas, P., Gabiot, A. C., Kantelip, B., Feger, F., Guillosson, J. J., Kantelip, J. P. and Arock, M., Autocrine regulation of cord blood-derived human mast cell activation by IL-10. J. Allergy Clin. Immunol. 2001. 108: 8086.
  • 36
    Lebel, B., A high-sampling-rate automated continuous-flow fluorometric technique for the analysis of nanogram levels of histamine in biological samples. Anal. Biochem. 1983. 133: 1629.